SSL Certificates
Home
Contact us
You have 0 item(s) in your cart.
Username
Password
Forgot Password?
Clinical Support
Home
Clinical Support
S.no.
Title
RadiaPlex
®
Rx Gel
1
Patients Undergoing Radiation Treatment Were Clinically Evaluated for Skin Integrity, Pain and Itching in a Preliminary Trial Using RadiaPlexRxT Gel Containing 0.2% Hyaluronic Acid. Moore K, Haas ML, Lloyd K. Oncology Nursing Forum, 2005;32;2;479.
2
RadiaPlexRx
TM
Gel Protects Cultured Skin Cells from Oxidative Free Radical Damage Induced by Hydrogen Peroxide and by Irradiation: A Pilot Study. R Gracy, Ph.D., K. Lloyd, M.S., J Phelps, Ph.D. Presented at Radiological Society of North America, 2004; 90th Scientific Assembly, SSA20-08;300.
3
A Pilot Study Evaluating Breast Cancer Patients Treated with a Topical Gel Containing 0.2% Hyaluronic acid for Efficacy Towards Radiation Dermatitis. M. Haas, Ph.D., ANP-C, Mountain Radiation Oncology, Ashville, NC, K. L. Lloyd, M.S. MPM Medical Inc., Irving TX
Regenecare
1
A pilot crossover study to evaluate the use of Regenecare topical wound gel in patients with cutaneous toxicity caused by epidermal growth factor receptor (HER1/EGFR) inhibitors.Citation: Journal of Clinical Oncology, 2007 ASCO Annual Meeting Proceedings Part I. Vol 25, No. 18S (June 20 Supplement), 2007: 19643 Author(s): S. Wong, K. E. Osann, K. P. Lloyd, C. M. Vasko, R. L. Arcinas, M. Mummaneni
2
A Pilot Cross-Over study to evaluate the use of Regenecare
®
topical gel in patients with cutaneous toxicity caused by epidermal growth factor receptor (HER1/EGFR) inhibitors. SF Wong, Pharm D. K Lloyd MS, C Vasko RN, OCN, NP, M Mummaneni M.D., K Osann PhD. Presented at 9th National Conference on Cancer Nursing Research, 2007, 126, Oncology Nursing Forum,
3
Evaluation of Regenecare
®
Topical Gel in the Treatment of Skin Rash Associated with Cetuximab (Erbitux
®
), Tarceva
®
and Other EGFR Inhibitors-Treated Cancer Patients. M. Kozloff, M.D., PA Gowland, RN, BSN, OCN, CCRC, J Vlamakis RN, OCN, J Koch RN BSN, G Ratko RN, BSN, L Gravitt RN, OCN, D Palmer CCRP, Ingalls Memorial Hospital, Cancer Research Center. Harvey Ill., 2007.
4
Evaluation of Cutaneous Skin Rash in Subjects Treated with Regenecare
®
Topical Gel (Collagen, Aloe vera, & 2% Lidocaine) During Erbitux
®
and Combination Therapies for Cancer. SF Wong, Pharm D, Western University of Health Sciences, College of Pharmacy, Pamona CA, Faculty in Residence Hematology Oncology Medical Group of Orange County, CA, Nov. 2006.
5
Case Studies Evaluating Regenecare
®
Topical Gel, with 2% Lidocaine HCl, Collagen & Aloe Vera for Treating Cutaneous Rash Associated with EGFR (HER!/EGFR) Inhibitors. S F Wong, Pharm D, Western University of Health Sciences, College of Pharmacy, Pamona CA, Faculty in Residence Hematology Oncology Medical Group of Orange County, Orange CA, Nov. 2006.
6
Regenecare
®
with Lidocaine Has Been Used Successfully on Over 400 Patients by Southwest Regional Wound Care Center, Lubbock, Texas to Anesthetize Wounds Prior to Debridement. Randall Wolcott M.D., P.A., American Professional Wound Care Association, 2006.
7
Evaluation of Tropical Gel(With 2% Lidocaine-HCI) for Treatment of Adverse Rash Sympotoms Associated With EGFR/HER1 Inhibitors M.F.Kozloff, P.A. Gowland, J.Vlamakis, J.Koch, K.P.Lloyd, J.B.Spalding Ingalls Memorial Hospital, Cancer Research Center, Harvey, Illinois; MPM Medical Inc., Irving, Texas; University of North Texas, Denton, Texas
8
A Cross-Over Clinical Study of Forty Seven Patients with Painful Deep Wounds Showed Regenecare
®
Hydrogel Application was Highly Significant in Alleviating Dressing Related Pain.
9
Pilot cross-over study to evaluate Regenecare topical gel in patients with epidermal growth factor receptor (HER1/EGFR) inhibitors-induced skin toxicity: The final analysis.
10
Evaluation of Regenecare
®
Topical Gel for Treatment of Adverse Rash Symptoms Associated with EGFR Inhibitors
11
Ten Patients with Painful Deep Wounds Evaluate Pain with Application of 2% Lidocaine Jelly Versus Regenecare® Wound Gel with 2% Lidocaine During Dressing Change
Biopad Collagen
1
Healing Diabetic Foot and Heel Ulcers with Biopad
®
, an Equine Type I Hetetologous Lyophilized Collagen Primary Wound Dressing
2
Biopad vs Promogram. Diabetic Foot Ulcer comparision
Enter term to search:
Products
Clinical Studies
Anti-Fungal
TM
Cream
Antiseptic Wound & Skin Cleanser
Collagen Wound Dressings
CoolMagic
TM
Sheet Hydrogel Dressing
Excel Hydrocolloid
Excel-Gel
TM
ExcelGinate AG Dressing
ExcelGinate Dressing
Foam Dressing Bordered & Non-Bordered
GelPad
®
Isolate Hydrophilic Foam Dressing
MPM Spot Dressing
Multi-Layered Bordered Composite Dressing
Multi-Layered Borderless Composite Dressing
Normlshield
®
Cream
Repel
TM
Wound Dressing (Composite)
SilverMed
TM
Hydrogel
Tulip Sacral Ulcer Wound Dressing
Wound & Skin Cleanser
WoundGard
®
CoolMagic
TM
Sheet Hydrogel Dressing
DermaPlex
TM
Gel
OraMagic
®
Plus Oral Wound Rinse
OraMagic
®
Rx - Oral Wound Care
RadiaPlex
®
Rx Gel
Regenecare
Regenecare HA
Regenecare HA Saturated Pads
Regenecare HA Spray
Radiation Dermatitis
SilverMed
TM
Hydrogel
Regenecare
Regenecare HA
RadiaPlex
®
Rx Gel
DermaPlex
TM
Gel
CoolMagic
TM
Sheet Hydrogel Dressing
Medical/Hematology Oncology/
Oral Care
Regenecare
Regenecare HA
Foam Dressing Bordered & Non-Bordered
OraMagic
®
Rx - Oral Wound Care
OraMagic
®
Plus Oral Wound Rinse
EGFR Rash/Hand and Foot Syndrome
Regenecare
Regenecare HA
Unique Design Protects Wound from Infiltration of Urine & Stool
The New Name in Pain Management.
Painful Deep Wounds.
The New Name in Pain Management.
Home
:
About Us
:
Wound Care
:
Pain Management
:
Oncology Care
:
Clinical Support
:
Contact us
2301 Crown Ct, Irving TX 75038, Telephone: (972)893-4090 Fax: (972)893-4092
MPM Medical is a wholly owned subsidiary of RBC Life Sciences, Inc.
© Copyright 2009 MPM Medical, INC. All rights reserved.
